Sennosides,Docusate sodium is a Oral Tablet, Film Coated in the Human Otc Drug category. It is labeled and distributed by Major Pharmaceuticals. The primary component is Sennosides; Docusate Sodium.
| Product ID | 0904-6724_780b838c-b1fa-442f-e053-2991aa0a7758 |
| NDC | 0904-6724 |
| Product Type | Human Otc Drug |
| Proprietary Name | Sennosides,Docusate sodium |
| Generic Name | Sennosides,docusate Sodium |
| Dosage Form | Tablet, Film Coated |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-12-20 |
| Marketing Category | OTC MONOGRAPH NOT FINAL / OTC MONOGRAPH NOT FINAL |
| Application Number | part334 |
| Labeler Name | Major Pharmaceuticals |
| Substance Name | SENNOSIDES; DOCUSATE SODIUM |
| Active Ingredient Strength | 9 mg/1; mg/1 |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2019-03-14 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | OTC monograph not final |
| Application Number | part334 |
| Product Type | HUMAN OTC DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2019-03-14 |
| Ingredient | Strength |
|---|---|
| SENNOSIDES | 8.6 mg/1 |
| SPL SET ID: | 780b838c-b1f9-442f-e053-2991aa0a7758 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI | |
| UPC Code |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0536-1169 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 0615-8276 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 0904-6724 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 55154-7299 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |
| 70518-1885 | Sennosides,Docusate sodium | Sennosides,Docusate sodium |